Silver(I)-silver(I) interactions in complexes of pentadentate macrocyclic ligands; crystal and molecular structure of [Ag₂L₂][BF₄]₂(L1,11-bis(2′-hydroxyethyl)-4,8; 12,16;17,21-trinitrilo-1,2,10,11-tetraazacyclohenicosa-2,4,6,9,12,14,18,20-octaene)

Edwin C. Constable^*, Muhammad S. Khan, Michael C. Liptrot, Jack Lewis, Paul R. Raithby

^*المؤلف المقابل لهذا العمل

نتاج البحث: المساهمة في مجلة › Article › مراجعة النظراء

بصمة

أدرس بدقة موضوعات البحث “Silver(I)-silver(I) interactions in complexes of pentadentate macrocyclic ligands; crystal and molecular structure of [Ag₂L₂][BF₄]₂(L1,11-bis(2′-hydroxyethyl)-4,8; 12,16;17,21-trinitrilo-1,2,10,11-tetraazacyclohenicosa-2,4,6,9,12,14,18,20-octaene)'. فهما يشكلان معًا بصمة فريدة.

فرز حسب
الوزن
أبجديًا

Silver(I)-silver(I) interactions in complexes of pentadentate macrocyclic ligands; crystal and molecular structure of [Ag₂L₂][BF₄]₂(L1,11-bis(2′-hydroxyethyl)-4,8; 12,16;17,21-trinitrilo-1,2,10,11-tetraazacyclohenicosa-2,4,6,9,12,14,18,20-octaene)

بصمة

Pharmacology, Toxicology and Pharmaceutical Science

Material Science

Silver(I)-silver(I) interactions in complexes of pentadentate macrocyclic ligands; crystal and molecular structure of [Ag2L2][BF4]2(L1,11-bis(2′-hydroxyethyl)-4,8; 12,16;17,21-trinitrilo-1,2,10,11-tetraazacyclohenicosa-2,4,6,9,12,14,18,20-octaene)

بصمة

Pharmacology, Toxicology and Pharmaceutical Science

Material Science

Silver(I)-silver(I) interactions in complexes of pentadentate macrocyclic ligands; crystal and molecular structure of [Ag₂L₂][BF₄]₂(L1,11-bis(2′-hydroxyethyl)-4,8; 12,16;17,21-trinitrilo-1,2,10,11-tetraazacyclohenicosa-2,4,6,9,12,14,18,20-octaene)